Inventor · disambiguated record
David M. Goldenberg
Also filed as: GOLDENBERG DAVID · GOLDENBERG DAVID M · GOLDENBERG DAVID MILTON
384 granted patents·160 pending applications·12,358 citations·filing 1991–2025
99Inventor score
Files withIMMUNOMEDICS INC353IBC PHARMACEUTICALS INC63CHANG CHIEN-HSING24GOLDENBERG DAVID M22CT MOLECULAR MED & IMMUNOLOGY13
Top patents by PatentIndex Score
544 records- 0199US11541047B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2020·Granted Jan 3, 2023·5 cites·16 claims
- 0299US9492566B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2015·Granted Nov 15, 2016·61 cites·22 claims
- 0399US8420086B2Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseasesGOVINDAN SERENGULAM V·Filed 2011·Granted Apr 16, 2013·68 cites·43 claims
- 0499US8349332B2Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseasesIBC PHARMACEUTICALS INC·Filed 2011·Granted Jan 8, 2013·58 cites·12 claims
- 0599US8268317B2Camptothecin-binding moiety conjugatesGOVINDAN SERENGULAM V·Filed 2009·Granted Sep 18, 2012·82 cites·34 claims
- 0699US8105596B2Immunotherapy of B-cell malignancies using anti-CD22 antibodiesGOLDENBERG DAVID M·Filed 2011·Granted Jan 31, 2012·54 cites·21 claims
- 0799US8080250B1Immunoconjugates with an intracellularly-cleavable linkageGOVINDAN SERENGULAM V·Filed 2011·Granted Dec 20, 2011·106 cites·15 claims
- 0899US8034352B2Tetrameric cytokines with improved biological activityIBC PHARMACEUTICALS INC·Filed 2010·Granted Oct 11, 2011·61 cites·6 claims
- 0999US7999083B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2009·Granted Aug 16, 2011·184 cites·13 claims
- 1099US7931903B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2010·Granted Apr 26, 2011·97 cites·38 claims
- 1199US7906121B2Methods and compositions for generating bioactive assemblies of increased complexity and usesIBC PHARMACEUTICALS INC·Filed 2009·Granted Mar 15, 2011·125 cites·25 claims
- 1299US7906118B2Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technologyIBC PHARMACEUTICALS INC·Filed 2009·Granted Mar 15, 2011·90 cites·17 claims
- 1399US7901680B2Dock-and-lock (DNL) vaccines for cancer therapyIBC PHARMACEUTICALS INC·Filed 2009·Granted Mar 8, 2011·92 cites·19 claims
- 1499US7772373B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2007·Granted Aug 10, 2010·114 cites·35 claims
- 1599US7666400B2PEGylation by the dock and lock (DNL) techniqueIBC PHARMACEUTICALS INC·Filed 2007·Granted Feb 23, 2010·158 cites·21 claims
- 1699US7662378B2Antibody therapyIMMUNOMEDICS INC·Filed 2007·Granted Feb 16, 2010·73 cites·18 claims
- 1799US7641901B2Immunotherapy of autoimmune disorders using antibodies which target B-cellsIMMUNOMEDICS INC·Filed 2005·Granted Jan 5, 2010·76 cites·47 claims
- 1899US7591994B2Camptothecin-binding moiety conjugatesIMMUNOMEDICS INC·Filed 2008·Granted Sep 22, 2009·129 cites·14 claims
- 1999US7563433B2Methods and compositions for F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2008·Granted Jul 21, 2009·64 cites·16 claims
- 2099US7550143B2Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and usesIBC PHARMACEUTICALS INC·Filed 2006·Granted Jun 23, 2009·177 cites·21 claims
- 2199US7534866B2Methods and compositions for generating bioactive assemblies of increased complexity and usesIBC PHARMACEUTICALS INC·Filed 2006·Granted May 19, 2009·287 cites·18 claims
- 2299US7527787B2Multivalent immunoglobulin-based bioactive assembliesIBC PHARMACEUTICALS INC·Filed 2006·Granted May 5, 2009·293 cites·23 claims
- 2399US7521056B2Stably tethered structures of defined compositions with multiple functions or binding specificitiesIBC PHARMACEUTICALS INC·Filed 2006·Granted Apr 21, 2009·297 cites·28 claims
- 2499US7312318B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Dec 25, 2007·243 cites·23 claims
- 2599US7109304B2Humanized anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2004·Granted Sep 19, 2006·240 cites·4 claims
- 2699US7074403B1Immunotherapy of autoimmune disorders using antibodies which target B-cellsIMMUNOMEDICS INC·Filed 2000·Granted Jul 11, 2006·226 cites·20 claims
- 2799US6653104B2Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cellsIMMUNOMEDICS INC·Filed 2001·Granted Nov 25, 2003·346 cites·140 claims
- 2899US6306393B1Immunotherapy of B-cell malignancies using anti-CD22 antibodiesIMMUNOMEDICS INC·Filed 1999·Granted Oct 23, 2001·674 cites·33 claims
- 2999US6183744B1Immunotherapy of B-cell malignancies using anti-CD22 antibodiesIMMUNOMEDICS INC·Filed 1998·Granted Feb 6, 2001·386 cites·23 claims
- 3098US11116846B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2020·Granted Sep 14, 2021·8 cites·16 claims
- 3198US11020489B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2020·Granted Jun 1, 2021·4 cites·16 claims
- 3298US10849986B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2020·Granted Dec 1, 2020·5 cites·15 claims
- 3398US10682347B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2018·Granted Jun 16, 2020·11 cites·18 claims
- 3498US10137196B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2016·Granted Nov 27, 2018·18 cites·20 claims
- 3598US9382329B2Disease therapy by inducing immune response to Trop-2 expressing cellsIBC PHARMACEUTICALS INC·Filed 2015·Granted Jul 5, 2016·23 cites·15 claims
- 3698US9315567B2T-cell redirecting bispecific antibodies for treatment of diseaseIBC PHARMACEUTICALS INC·Filed 2013·Granted Apr 19, 2016·47 cites·10 claims
- 3798US9187561B2Humanized anti-HLA-DR antibodiesIMMUNOMEDICS INC·Filed 2014·Granted Nov 17, 2015·35 cites·21 claims
- 3898US9138485B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2014·Granted Sep 22, 2015·32 cites·15 claims
- 3998US9028833B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2013·Granted May 12, 2015·48 cites·22 claims
- 4098US8992917B2Humanized L243 antibodiesIMMUNOMEDICS INC·Filed 2013·Granted Mar 31, 2015·37 cites·23 claims
- 4198US8759496B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2012·Granted Jun 24, 2014·38 cites·16 claims
- 4298US8597659B2Tetrameric cytokines with improved biological activityCHANG CHIEN-HSING·Filed 2011·Granted Dec 3, 2013·50 cites·12 claims
- 4398US8562988B2Strategies for improved cancer vaccinesCHANG CHIEN-HSING·Filed 2010·Granted Oct 22, 2013·44 cites·16 claims
- 4498US8551480B2Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activityCHANG CHIEN-HSING·Filed 2010·Granted Oct 8, 2013·48 cites·3 claims
- 4598US8475794B2Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseasesCHANG CHIEN-HSING·Filed 2011·Granted Jul 2, 2013·44 cites·7 claims
- 4698US8435529B2Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapyGOVINDAN SERENGULAM V·Filed 2010·Granted May 7, 2013·30 cites·19 claims
- 4798US8282934B2Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technologyCHANG CHIEN-HSING·Filed 2011·Granted Oct 9, 2012·49 cites·17 claims
- 4898US8277817B2PEGylation by the dock and lock (DNL) techniqueCHANG CHIEN-HSING·Filed 2011·Granted Oct 2, 2012·44 cites·11 claims
- 4998US8246960B2Methods and compositions for generating bioactive assemblies of increased complexity and usesCHANG CHIEN-HSING·Filed 2011·Granted Aug 21, 2012·55 cites·21 claims
- 5098US8211440B2Multivalent immunoglobulin-based bioactive assembliesCHANG CHIEN-HSING·Filed 2010·Granted Jul 3, 2012·57 cites·25 claims
Showing the top 50 of 544 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David M. Goldenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →